FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2885489314> ?p ?o ?g. }

• W2885489314 endingPage "A184" @default.
• W2885489314 startingPage "A184" @default.
• W2885489314 abstract "Abstract Aim: To investigate feasibility and utility of whole genome and RNA sequencing in cancer care. The use of comprehensive personal genomic information to guide cancer treatment decisions has gained momentum in recent years. Here we present the Personalized Oncogenomics (POG) project launched at British Columbia Cancer Agency in 2012. This project uses paired tumor/normal whole genome and transcriptome sequencing to characterize a patient's tumor and inform treatment options within a clinically relevant time frame. In the past 5 years, around 600 patients with metastatic cancers (including 49 pediatric cases) have been sequenced and analyzed, representing over 50 cancer types. The breadth and depth of data in POG enable the detection of multiple types of alterations, from simple mutations, indels, and copy number changes, to more complex alterations such as gene fusion, mutation signatures, and homologous recombination deficiency score. Incorporation of gene expression data through transcriptome sequencing informs on the impact of observed genomic alterations, and provides information regarding specific diagnosis via expression comparison to other cancer subtypes. All genomic and transcriptomic variants are integrated to build a personalized tumor-specific molecular profile, identify actionable items supported by an in-house knowledgebase and publically available molecular oncology, and characterize each individual tumor by intensive pathway analysis and literature search. Such multidimensional data also impose challenges in interpretation and communication. We developed a pipeline to translate complex genomic data into clinically actionable and hypothetical recommendations for the treatment of individual patients. The pipeline produces two reports: a panel-like report that contains known SNVs and fusions with therapeutic relevance from a collection of more than 4000 events, and a second comprehensive and manually curated report to fully characterize the tumor using the whole genome and transcriptome datasets. Genomic data are presented and discussed at a multidisciplinary molecular tumor board consisting of medical oncologists, pathologists, bioinformaticians, geneticists, and biologists. This approach has enabled clinicians to make informed clinical decisions based on the genomic data integrated with other clinical features, as well as to form new treatment-related hypothesis. POG has shown that use of both whole genome and transcriptome sequencing allows identification of therapeutic targets in a significant proportion of patients. Almost 80% cases were found to have one or more actionable alterations (100% in pediatric cases), and almost one-third of these are defined only using RNA data. Based on molecular tumor board discussion, patients are directed to clinical trials, positioned to genomically informed standard-of-care options, or treated with off-label drugs. With demonstrated effectiveness, the integrative approach developed by POG not only provides molecular insight and treatment options into individual tumors, but also provides a rich resource of molecular data with matched clinical information that will aid our understanding of tumor biology and therapy response mechanisms to inform treatment strategies in the future. Citation Format: Yaoqing Shen, Martin R. Jones, Erin Pleasance, Melika Bonakdar, Carolyn Ch'ng, Caralyn Reisle, Laura Williamson, Elisa Majounie, Greg Taylor, Simon Chan, Brandon Pierce, Wei Zhang, Amir Muhammadzadeh, Eric Y. Zhao, Dustin Bleile, Karen Mungall, Nina Thiessen, Eric Chuah, Tina Wong, Richard Corbett, Yussanne Ma, Richard A. Moore, Andrew J. Mungall, Yongjun Zhao, Stephen Yip, Anna F. Lee, Rod Rassekh, Rebecca Deyell, Howard Lim, Daniel Renouf, Robyn Roscoe, Steven J.M Jones, Janessa Laskin, Marco A. Marra. Clinical application of whole genome and transcriptome sequencing in cancer care [abstract]. In: Proceedings of the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; 2017 Oct 26-30; Philadelphia, PA. Philadelphia (PA): AACR; Mol Cancer Ther 2018;17(1 Suppl):Abstract nr A184." @default.
• W2885489314 created "2018-08-22" @default.
• W2885489314 creator A5000837665 @default.
• W2885489314 creator A5001731680 @default.
• W2885489314 creator A5009267215 @default.
• W2885489314 creator A5009654096 @default.
• W2885489314 creator A5012789041 @default.
• W2885489314 creator A5014010589 @default.
• W2885489314 creator A5014318555 @default.
• W2885489314 creator A5014948069 @default.
• W2885489314 creator A5015074167 @default.
• W2885489314 creator A5030969029 @default.
• W2885489314 creator A5044366354 @default.
• W2885489314 creator A5044705149 @default.
• W2885489314 creator A5045899559 @default.
• W2885489314 creator A5049385540 @default.
• W2885489314 creator A5050503254 @default.
• W2885489314 creator A5052650725 @default.
• W2885489314 creator A5053876463 @default.
• W2885489314 creator A5057226798 @default.
• W2885489314 creator A5059982490 @default.
• W2885489314 creator A5062939544 @default.
• W2885489314 creator A5065443817 @default.
• W2885489314 creator A5065566745 @default.
• W2885489314 creator A5070061359 @default.
• W2885489314 creator A5070218935 @default.
• W2885489314 creator A5071831090 @default.
• W2885489314 creator A5076699095 @default.
• W2885489314 creator A5083208901 @default.
• W2885489314 creator A5087284685 @default.
• W2885489314 creator A5088331751 @default.
• W2885489314 creator A5089913686 @default.
• W2885489314 creator A5091086534 @default.
• W2885489314 creator A5091115005 @default.
• W2885489314 date "2018-01-01" @default.
• W2885489314 modified "2023-10-12" @default.
• W2885489314 title "Abstract A184: Clinical application of whole genome and transcriptome sequencing in cancer care" @default.
• W2885489314 doi "https://doi.org/10.1158/1535-7163.targ-17-a184" @default.
• W2885489314 hasPublicationYear "2018" @default.
• W2885489314 type Work @default.
• W2885489314 sameAs 2885489314 @default.
• W2885489314 citedByCount "0" @default.
• W2885489314 crossrefType "journal-article" @default.
• W2885489314 hasAuthorship W2885489314A5000837665 @default.
• W2885489314 hasAuthorship W2885489314A5001731680 @default.
• W2885489314 hasAuthorship W2885489314A5009267215 @default.
• W2885489314 hasAuthorship W2885489314A5009654096 @default.
• W2885489314 hasAuthorship W2885489314A5012789041 @default.
• W2885489314 hasAuthorship W2885489314A5014010589 @default.
• W2885489314 hasAuthorship W2885489314A5014318555 @default.
• W2885489314 hasAuthorship W2885489314A5014948069 @default.
• W2885489314 hasAuthorship W2885489314A5015074167 @default.
• W2885489314 hasAuthorship W2885489314A5030969029 @default.
• W2885489314 hasAuthorship W2885489314A5044366354 @default.
• W2885489314 hasAuthorship W2885489314A5044705149 @default.
• W2885489314 hasAuthorship W2885489314A5045899559 @default.
• W2885489314 hasAuthorship W2885489314A5049385540 @default.
• W2885489314 hasAuthorship W2885489314A5050503254 @default.
• W2885489314 hasAuthorship W2885489314A5052650725 @default.
• W2885489314 hasAuthorship W2885489314A5053876463 @default.
• W2885489314 hasAuthorship W2885489314A5057226798 @default.
• W2885489314 hasAuthorship W2885489314A5059982490 @default.
• W2885489314 hasAuthorship W2885489314A5062939544 @default.
• W2885489314 hasAuthorship W2885489314A5065443817 @default.
• W2885489314 hasAuthorship W2885489314A5065566745 @default.
• W2885489314 hasAuthorship W2885489314A5070061359 @default.
• W2885489314 hasAuthorship W2885489314A5070218935 @default.
• W2885489314 hasAuthorship W2885489314A5071831090 @default.
• W2885489314 hasAuthorship W2885489314A5076699095 @default.
• W2885489314 hasAuthorship W2885489314A5083208901 @default.
• W2885489314 hasAuthorship W2885489314A5087284685 @default.
• W2885489314 hasAuthorship W2885489314A5088331751 @default.
• W2885489314 hasAuthorship W2885489314A5089913686 @default.
• W2885489314 hasAuthorship W2885489314A5091086534 @default.
• W2885489314 hasAuthorship W2885489314A5091115005 @default.
• W2885489314 hasConcept C104317684 @default.
• W2885489314 hasConcept C119054055 @default.
• W2885489314 hasConcept C121608353 @default.
• W2885489314 hasConcept C135763542 @default.
• W2885489314 hasConcept C141231307 @default.
• W2885489314 hasConcept C141674004 @default.
• W2885489314 hasConcept C150194340 @default.
• W2885489314 hasConcept C153209595 @default.
• W2885489314 hasConcept C162317418 @default.
• W2885489314 hasConcept C163763905 @default.
• W2885489314 hasConcept C189206191 @default.
• W2885489314 hasConcept C205270622 @default.
• W2885489314 hasConcept C24103923 @default.
• W2885489314 hasConcept C24432333 @default.
• W2885489314 hasConcept C32220436 @default.
• W2885489314 hasConcept C51679486 @default.
• W2885489314 hasConcept C54355233 @default.
• W2885489314 hasConcept C60644358 @default.
• W2885489314 hasConcept C70721500 @default.
• W2885489314 hasConcept C86803240 @default.
• W2885489314 hasConceptScore W2885489314C104317684 @default.
• W2885489314 hasConceptScore W2885489314C119054055 @default.
• W2885489314 hasConceptScore W2885489314C121608353 @default.

• next